Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits

Nature

Volumn 455, Issue 7214, 2008, Pages 804-807

  Brandl, Katharina ^a,d   Plitas, George ^a   Mihu, Coralia N ^a,c   Ubeda, Carles ^a   Jia, Ting ^a   Fleisher, Martin ^a   Schnabl, Bernd ^b,e   Dematteo, Ronald P ^a   Pamer, Eric G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; DECTIN 2; ENROFLOXACIN; LIPOPOLYSACCHARIDE; METRONIDAZOLE; NEOMYCIN; REGIIIGAMMA PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL DISEASE; BACTERIUM; EXPERIMENTAL STUDY; GENE EXPRESSION; IMMUNE SYSTEM; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; DOWN REGULATION; ENTEROCOCCACEAE; ENTEROCOCCAL INFECTION; GASTROINTESTINAL INFECTION; GENE EXPRESSION REGULATION; HUMAN; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; VANCOMYCIN RESISTANT ENTEROCOCCI;

ANIMALS; DOWN-REGULATION; ENTEROCOCCUS; IMMUNITY, NATURAL; INTESTINES; LIPOPOLYSACCHARIDES; MICE; MYELOID DIFFERENTIATION FACTOR 88; PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; VANCOMYCIN; VANCOMYCIN RESISTANCE;

ENTEROCOCCUS; MUS; POSIBACTERIA;

EID: 53649098280     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature07250     Document Type: Article

References (28)

1. Rice, L. B. Emergence of vancomycin-resistant enterococci. Emerg. Infect. Dis. 7, 183-187 (2001).
2. Rice, L. B. Antimicrobial resistance in gram-positive bacteria. Am. J. Infect. Control 34, S11-S19 (2006).
3. Murray, B. E. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342, 710-721 (2000).
4. Richards, M. J., Edwards, J. R., Culver, D. H. & Gaynes, R. P. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect. Control Hosp. Epidemiol. 21, 510-515 (2000).
5. Wenzel, R. P. & Edmond, M. B. Managing antibiotic resistance. N. Engl. J. Med. 343, 1961-1963 (2000).
6. Donskey, C. J. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin. Infect. Dis. 39, 219-226 (2004).
7. Cash, H. L., Whitham, C. V., Behrendt, C. L. & Hooper, L. V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313, 1126-1130 (2006).
8. Hooper, L. V., Stappenbeck, T. S., Hong, C. V. & Gordon, J. I. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nature Immunol. 4, 269-273 (2003).
9. Brandl, K., Plitas, G., Schnabl, B., DeMatteo, R. P. & Pamer, E. G. MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J. Exp. Med. 204, 1891-1900 (2007).
10. Cash, H. L., Whitham, C. V. & Hooper, L. V. Refolding, purification, and characterization of human and murine RegIII proteins expressed in Escherichia coli. Protein Expr. Purif. 48, 151-159 (2006).
11. Donskey, C. J. et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N. Engl. J. Med. 343, 1925-1932 (2000).
12. Miyazaki, S. et al. Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice. J. Med. Microbiol. 50, 695-701 (2001).
13. Stiefel, U., Pultz, N. J., Helfand, M. S. & Donskey, C. J. Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice. Infect. Control Hosp. Epidemiol. 25, 373-379 (2004).
14. Wells, C. L., Jechorek, R. P. & Erlandsen, S. L. Evidence for the translocation of Enterococcus faecalis across the mouse intestinal tract. J. Infect. Dis. 162, 82-90 (1990).
15. Wells, C. L., Jechorek, R. P., Maddaus, M. A. & Simmons, R. L. Effects of clindamycin and metronidazole on the intestinal colonization and translocation of enterococci in mice. Antimicrob. Agents Chemother. 32, 1769-1775 (1988).
16. Sonnenburg, J. L., Chen, C. T. & Gordon, J. I. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol. 4, e413 (2006).
17. Pultz, N. J., Stiefel, U., Subramanyan, S., Helfand, M. S. & Donskey, C. J. Mechanisms by which anaerobic microbiota inhibit the establishment in mice of intestinal colonization by vancomycin-resistant Enterococcus. J. Infect. Dis. 191, 949-956 (2005).
18. Kelly, C. P., Pothoulakis, C. & LaMont, J. T. Clostridium difficile colitis. N. Engl. J. Med. 330, 257-262 (1994).
19. Kanzler, H., Barrat, F. J., Hessel, E. M. & Coffman, R. L. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nature Med. 13, 552-559 (2007).
20. Abreu, M. T., Fukata, M. & Arditi, M. TLR signaling in the gut in health and disease. J. Immunol. 174, 4453-4460 (2005).
21. Lotz, M., Menard, S. & Hornef, M. Innate immune recognition on the intestinal mucosa. Int. J. Med. Microbiol. 297, 379-392 (2007).
22. Cario, E. et al. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol. 164, 966-972 (2000).
23. Hornef, M. W., Frisan, T., Vandewalle, A., Normark, S. & Richter-Dahlfors, A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med. 195, 559-570 (2002).
24. Ortega-Cava, C. F. et al. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J. Immunol. 170, 3977-3985 (2003).
25. Pull, S. L., Doherty, J. M., Mills, J. C., Gordon, J. I. & Stappenbeck, T. S. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl Acad. Sci. USA 102, 99-104 (2005).
26. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
27. Nenci, A. et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446, 557-561 (2007).
28. Hammett-Stabler, C. A. & Johns, T. Laboratory guidelines for monitoring of antimicrobial drugs. Clin. Chem. 44, 1129-1140 (1998).